CTNI-41. RESULTS OF A SINGLE-ARM, OPEN-LABEL, MULTICENTER PHASE 2 STUDY OF THE RADIOPHARMACEUTICAL [177LU]LU-DOTA-TATE IN ADULTS WITH ADVANCED INTRACRANIAL MENINGIOMASylvia C. Kurz, Erik P. Sulman, Marissa Barbaro et al.|Neuro-Oncology|2025Cited by 1
Final results of a single-arm, open-label, multicenter phase 2 study of the radiopharmaceutical [ <sup>177</sup> Lu]Lu-DOTA-TATE and [ <sup>68</sup> Ga]Ga-DOTA-TATE in adults with advanced intracranial meningioma.Sylvia C. Kurz, Timothy Shepherd, Elçin Zan et al.|Journal of Clinical Oncology|2026Cited by 0